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ABSTRACT 
BACKGROUND 
Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis(TEN) are 
severe cutaneous adverse reactions of major concern because of its high mortality. 
The prognosis of Stevens-Johnson syndrome and Toxic Epidermal necrolysis is 
widely assessed with SCORTEN (SCORe of TEN). Although, it is a largely useful 
scale, the predictive ability is still variable. Few modifications are suggested to the 
existing scale based on our study. 
OBJECTIVES 
This study was conducted to assess the clinicoetiological profile and outcome of 
SJS and TEN and to evaluate the validity of SCORTEN in assessing the prognosis 
in South Indian population. 
METHODS  
This prospective observational study was conducted in the Department of 
Dermatology, Venereology and Leprosy, Tirunelveli Medical College from 
January 2016 to June 2017 after obtaining Institutional ethical committee 
clearance. All the patients were admitted. Detailed history, examination, 
investigations and treatment details of the patients were recorded in a pre-set 
questionnaire. SCORTEN’s accuracy in predicting the mortality was assessed on 
day 1, 3 and 5 of admission. Conservative management and corticosteroids were 
the main stay of therapy in our study. Intravenous immunoglobulin was used in 
one patient. Patients were followed up for 3 months after discharge and follow up 
changes were noted. 
RESULTS 
The incidence of SJS/TEN among other drug reactions was 29.5%.  The most 
common age group affected was 30-49years (41.1%), with male preponderance 
(76.5%).  The age range of patients was 6 and 67 years. TEN (64.7%) was the 
predominant spectrum followed by SJS and SJS-TEN Overlap in 17.6% each. 
Anticonvulsants (47%) were the commonest causative drug, followed by 
analgesics (35%) and antibiotics (11%). The validity of SCORTEN was same on 
day 1, 3 and 5. There was good agreement between the actual and predicted 
mortality on all three days. Three patients (17.6%) (2 SJS-TEN Overlap with score 
of 5 and 6, 1 TEN with score 6) died in our study. All of them had 
thrombocytopenia. 2SJS-TEN Overlap patients, although with less BSA 
involvement succumbed to death because of CKD as co-morbidity. All survivors 
had a score of 4 or less. Four patients had 100% BSA involvement but only one 
with co-morbidity (carcinoma lung) died. The predicted mortalities were 0.417, 
1.836 and 2.574 and the observed mortalities were 0, 2 and 1 in SJS, SJS-TEN 
Overlap and TEN respectively.  
CONCLUSION 
Analysis of SCORTEN on single day either day 1, 3 or 5 is as useful as the serial 
analysis. SCORTEN gave a significant estimation of mortality in SJS-TEN 
Overlap patients, whereas it gave an overestimation of mortality in TEN patients. 
Inclusion of new parameters like thrombocytopenia and pulmonary infiltrates was 
recommended by us. Further studies on a larger scale, is needed to validate the 
modified SCORTEN proposed by us. 
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